| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-82 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-82 |
| filingDate |
2000-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d42cc8ca7049d506e5a30e8640b4101
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c4b3ee6c948976e1c0209702f59afeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb5c8b869f38ed0d01d37c6e2b228b2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_271b003147cc2459c1e62b2c30525ee5 |
| publicationDate |
2004-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2224258-C2 |
| titleOfInvention |
Method for identifying person with the risk of non reversible neurological lesions including stages for quantitative detection of pepsinogen i (pg i) and vitamin b 12 concentrations |
| abstract |
FIELD: medicine. SUBSTANCE: the present innovation deals with the stages for quantitative detecting concentration of analyzed pepsinogen I (PG I) in person's serum sample, matching specific cut-off value for the mentioned analyzed substance, comparing concentration of analyzed substance detected by this method and detecting vitamin B 12 concentration or it-correlating concentration of analyzed substance in serum sample. The present innovation gives increased number of preparations for detecting the risk in developing non reversible neurological lesion and pernicious anemia. EFFECT: higher efficiency of identification and detection. 5 cl |
| priorityDate |
1999-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |